Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
Fred Hutchinson Cancer Center
Thomas Jefferson University
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
University of Chicago
City of Hope Medical Center
Stanford University
Barbara Ann Karmanos Cancer Institute
Nohla Therapeutics, Inc.
Case Comprehensive Cancer Center
Stanford University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
The Cleveland Clinic
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Gruppo Italiano Malattie EMatologiche dell'Adulto
Eastern Cooperative Oncology Group
University of Washington
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute